Autor: Firma WELDING

Deepening Technical Expertise in Pet Food

8. September 2026 Firma WELDINGProduktionstechnikdigestibility, extrusion, feedstock, gelling agents, high quality, microencapsulation, nutraceuticals, palatability, pet food, reliable, sensoryanalysis, shelf life, stabilizers, technical expertise, training session

WELDING FEED, part of the WELDING Group, is deepening its collaboration with WELDING FOOD and its partner Eurogum – Bang & Bonsomer. By combining feed and food expertise, the partners support pet food manufacturers in developing reliable, high-quality products. Following Mehr

Quinine 200 mg Film-Coated Tablets (DCP Start)

2. September 2026 Firma WELDINGAllgemein200 mg, antimalarial, biosimilar, commercialization, dcp, Decentralized Procedure, Film-Coated Tablets, generic medicines, medicinal formulation, pharmacovigilance, product licensing, Quinine, quinoline, regulatory approval, supply chain

Quinine 200 mg Film-Coated Tablets (DCP Start) The company has started the Decentralized Procedure (DCP) for Quinine 200 mg Film-Coated Tablets, marking a new step in the expansion of its European generic portfolio. Building on decades of experience in Mehr

WELDING GmbH & Co. KG, through its business unit PHARMA FDF, announces its first European marketing authorizations for Tafamidis 61 mg soft capsules

29. Mai 2026 Firma WELDINGAllgemeinbiosimilar development, Decentralized Procedure, drug registration, EMA approval, generic medication, international pharma market, market authorization, marketing authorizations, multi country generic approval, pharmaceutical licensing, regulatory expertise, regulatory pathway, supply resilience, Tafamidis 61 mg soft capsules, value-based partnerships

WELDING GmbH & Co. KG announces an important regulatory milestone in Europe. Following the successful closure of the Decentralized Procedure (DCP) earlier this year, WELDING GmbH & Co. KG in collaboration with its partner Zenara Pharma Pvt Ltd has received its Mehr

WELDING GmbH & Co. KG Expands to Latin America

27. Mai 2026 Firma WELDINGFirmeninternActive Pharmaceutical Ingredients, competitive pricing, distribution expertise, Food Additives, functional nutrition, ingredient sourcing, international subsidiary, Latin American market, manufacturing standards, Market expansion, mexico, pharmaceutical distribution, Regulatory Compliance, Supply Chain Resilience, traceability systems

WELDING GmbH & Co. KG announces the establishment of its Mexican subsidiary, WELDING Ingredientes SA de CV. With this step, our family-owned company is expanding its international presence and strengthening its position in the Latin American market. Our goal is Mehr

Revio Therapeutics and Welding Group Announce Strategic Co-Development and Licensing Agreement for Innovative Specialty Oncology Product

24. März 202624. März 2026 Firma WELDINGAllgemeinbiotechnology, cancer, drug development, healthcare innovation, Market Access, oncology, partnership, patient care, Regulatory Compliance, Revio, specialty pharmaceuticals, therapeutics

Revio Therapeutics ("Revio") and Welding Group ("Welding") today announced the signing of a co-development and licensing agreement for Revio’s proprietary specialty oncology product. The 505(b)(2) product, designed based on an innovative dosage form with significant patient compliance and ease-of-use advantages, will be developed Mehr